checkAd

EQS-Adhoc IGEA calls extraordinary general meeting

Nachrichtenquelle: EQS Group AG
22.03.2021, 21:35  |  141   |   |   

EQS Group-Ad-hoc: IGEA Pharma N.V. / Key word(s): Miscellaneous
IGEA calls extraordinary general meeting

22-March-2021 / 21:35 CET/CEST
Release of an ad hoc announcement pursuant to Art. 18 KR
The issuer is solely responsible for the content of this announcement.


FOR RELEASE IN SWITZERLAND - THIS IS A RESTRICTED COMMUNICATION AND YOU MUST NOT FORWARD IT OR ITS CONTENTS TO ANY PERSON TO WHOM FORWARDING THIS COMMUNICATION IS PROHIBITED. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN.

IGEA calls extraordinary general meeting

Hoofddorp, the Netherlands, 22 March 2021. IGEA Pharma N.V. (SIX: IGPH) today announced the convening of an extraordinary general meeting (the "EGM") for Wednesday, 28 April 2021. The EGM will resolve on matters regarding the business combination with Blue Sky Natural Resources LTD ("BSNR") as further indicated below (and as previously disclosed by IGEA on 8 August 2020 and 15 February 2021) and on the appointment of newly proposed non-executive directors.

The business combination has been structured through a contribution in-kind by the BSNR shareholders of their ownership in BSNR into IGEA by subscribing IGEA's newly issued shares. The reference value of BSNR has been set by the board of IGEA in CHF 186 million (on a fully diluted and post-money basis). Accordingly, the board will propose to the EGM the issuance of up to 309'600'000 new shares of IGEA (the "New Shares"), with exclusion of any pre-emptive right. The New Shares will be reserved for issuance to the shareholders of BSNR only. Issuance will be at par and payment will be by contribution in-kind of the BSNR shares only, according to the provisions of article 2:94b of the Civil Code. In case of fractions, the figures will be rounded down to the nearest New Shares' unit. The percentage in the share capital of BSNR not contributed-in will result in an equal reduction in the New Shares, provided however that at least 75% of the share capital (on a fully diluted basis) and the votes of BSNR shall be achieved for considering the transaction as completed. The satisfaction of further conditions customary for a transaction of this type remain valid until the EGM.

Seite 1 von 5
IGEA Pharma Aktie jetzt über den Testsieger (Finanztest 11/2020) handeln, ab 0 € auf Smartbroker.de



Diesen Artikel teilen

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

EQS-Adhoc IGEA calls extraordinary general meeting EQS Group-Ad-hoc: IGEA Pharma N.V. / Key word(s): Miscellaneous IGEA calls extraordinary general meeting 22-March-2021 / 21:35 CET/CEST Release of an ad hoc announcement pursuant to Art. 18 KR The issuer is solely responsible for the content of …

Community

Nachrichten des Autors

Titel
Titel
Titel
Titel